Discover 1,397 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,397
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Westlake OH, Avon Lake OH, Bloomfield Hills MI,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
for
Multiple Myeloma
Location: Cleveland OH, Pittsburgh PA, Indianapolis IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04133636
Phase2, Recruiting
Active & Responsive
Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
for
Allogeneic Hematopoietic Cell Transplantation
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT04332341
Early_phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Phenotypic Classification of FMR With CMR
for
Nonischemic Congestive Cardiomyopathy,
Location: Cleveland OH
Sponsor: The Cleveland Clinic
Sex: All
Age: 18+
Code: NCT05965258
Recruiting
Active & Responsive
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Location: Cleveland OH, Cincinnati OH, Boston MA, Los Angeles CA,
Sponsor: Boston Children's Hospital
Sex: All
Age: 18+
Code: NCT02461446
Recruiting
Active & Responsive
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
for
Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer,
Location: Cleveland OH, Detroit MI, Grand Rapids MI, Fairfax VA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 18+
Code: NCT04198766
Phase1, Phase2, Recruiting
Active & Responsive
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Cleveland OH, New Brunswick NJ, New York NY,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05932862
Phase1, Recruiting
Active & Responsive
The Cancer of the Pancreas Screening-5 CAPS5)Study